Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer
Not Applicable
- Conditions
- non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000002383
- Lead Sponsor
- ung Oncology Group in Kyushu, Japan (LOGIK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1)Past history of drug hypersensitivity 2)Past history of myocardial infarction within 6 months 3)Interstitial pneumonia or active lung fibrosis 4)Uncontrolled heart diseases 5)Uncontrolled psychiatric disorders 6)Uncontrolled diabetes 7)Bowel problems 8)Active infection 9)Severe complications 10)Active concomitant malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of patients who accomplished S-1 therapy of eight courses.
- Secondary Outcome Measures
Name Time Method Adverse events The relative total administration dose of S-1